B. A. C. Dijkmans

2.6k citations

24 papers · 1.9k indexed · 1 hit paper · h-index 13

Rheumatology top 0.5%
- Rheumatoid Arthritis Research and Therapies 15
- Systemic Lupus Erythematosus Research 7
- Spondyloarthritis Studies and Treatments 5
- Urticaria and Related Conditions 2
Hematology top 5%
- Autoimmune and Inflammatory Disorders Research 3
Immunology top 10%
Cardiology and Cardiovascular Medicine top 5%
Hepatology top 10%
Orthopedics and Sports Medicine
- Bone and Joint Diseases 4
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4
Genetics
- Chronic Lymphocytic Leukemia Research 3

Co-authors: Michael T. Nurmohamed Tore K Kvien Iain B. McInnes Naveed Sattar Zoltán Szekanecz Prodromos Sidiropoulos David McCarey M.J. Peters
Cited by: Rheumatology Hematology Immunology
Journals: Annals of the Rheumatic Diseases (10 papers)Osteoporosis International (1 paper)Lara D. Veeken (3 papers)
Partner nations: Netherlands United Kingdom Norway

In The Last Decade

B. A. C. Dijkmans

24 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by B. A. C. Dijkmans

Since Specialization

Citations

This map shows the geographic impact of B. A. C. Dijkmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. A. C. Dijkmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. A. C. Dijkmans more than expected).

Fields of papers citing papers by B. A. C. Dijkmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. A. C. Dijkmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. A. C. Dijkmans. The network helps show where B. A. C. Dijkmans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B. A. C. Dijkmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. A. C. Dijkmans Line = papers co-authored together B. A. C. Dijkmans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies Lara D. Veeken ·Diane van der Woude,K. Visser,Naomi B. Klarenbeek,H. K. Ronday,A. J. Peeters,P.J.S.M. Kerstens,B. A. C. Dijkmans,T. Huizinga,Annette H M van der Helm–van Mil,C.F. Allaart	2012	32
2	AB0889 Low percentage of MRI changes in clinically suspected axial spondyloarthritis Annals of the Rheumatic Diseases ·Irene van der Horst‐Bruinsma,M. van der Weijden,Stefan Bruijnen,S. Weismann,Pierre M. Bet,C. van Kuijk,Jos W. R. Twisk,B. A. C. Dijkmans,C. van der Laken,M. Nurmohamed	2012	1
3	The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study Annals of the Rheumatic Diseases ·Maries van den Broek,Linda Dirven,NB Klarenbeek,THE Molenaar,KH Han,PJSM Kerstens,T. Huizinga,B. A. C. Dijkmans,Cornelia F Allaart	2011	72
4	High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis Osteoporosis International ·Marijn Vis,Espen A. Haavardsholm,Pernille Bøyesen,Glenn Haugeberg,Till Uhlig,Mari Hoff,Anthony D. Woolf,B. A. C. Dijkmans,W.F. Lems,Tore K Kvien	2011	53
5	Simplified versions of the original disease activity score: validation in the BeSt trial Annals of the Rheumatic Diseases ·Rosanne Koevoets,Naomi B. Klarenbeek,Melek Güler-Yüksel,M. van Oosterhout,M V van Krugten,P. Kerstens,T. Huizinga,B. A. C. Dijkmans,D. van der Heijde,C. Allaart	2011	9
6	The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia Annals of the Rheumatic Diseases ·Lotte A van de Stadt,A. R. van der Horst,Margret H. M. T. De Koning,Wouter H Bos,Gertjan Wolbink,R J van de Stadt,G.J.M. Pruijn,B. A. C. Dijkmans,Dirkjan van Schaardenburg,D. Hamann	2010	137
7	Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial Annals of the Rheumatic Diseases ·Naomi B. Klarenbeek,S M van der Kooij,T. Huizinga,Y P M Goekoop-Ruiterman,H. M. J. Hulsmans,M V van Krugten,I. Speyer,Jeska K de Vries‐Bouwstra,P. J. S. M. Kerstens,B. A. C. Dijkmans,C. F. Allaart	2010	51
8	Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study Annals of the Rheumatic Diseases ·Wouter H Bos,Gertjan Wolbink,Maarten Boers,G.J. Tijhuis,Niek de Vries,Irene E. van der Horst‐Bruinsma,Paul P. Tak,R J van de Stadt,Conny J. van der Laken,B. A. C. Dijkmans,Dirkjan van Schaardenburg	2009	208
9	Lack of effect of TNFα blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies Annals of the Rheumatic Diseases ·Matthew Peters,P. Watt,Lois M. Cherry,Paul Welsh,Evelyn Henninger,B. A. C. Dijkmans,Iain B. McInnes,Michael T. Nurmohamed,Naveed Sattar	2009	31
10	Reproducibility of performance measures of physical function based on the BASFI, in ankylosing spondylitis Lara D. Veeken ·Salima van Weely,Christiaan J van Denderen,Irene van der Horst‐Bruinsma,Michael T. Nurmohamed,B. A. C. Dijkmans,Joost Dekker,Martijn Steultjens	2009	29
11	EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisbreakdown → Annals of the Rheumatic Diseases ·M.J. Peters,Deborah Symmons,David McCarey,B. A. C. Dijkmans,Paulo Nicola,Tore K Kvien,Iain B. McInnes,H Haentzschel,Miguel Á. González‐Gay,Sella Aarrestad Provan,Anne Grete Semb,Prodromos Sidiropoulos,George D. Kitas,Yvo M. Smulders,Martin Soubrier,Zoltán Szekanecz,Naveed Sattar,Michael T. Nurmohamed	2009	969
12	Progression of joint damage in early rheumatoid arthritis: Association with HLA–DRB1, rheumatoid factor, and anti–citrullinated protein antibodies in relation to different treatment strategies Arthritis & Rheumatism ·Jeska K de Vries‐Bouwstra,Y P M Goekoop-Ruiterman,K. N. Verpoort,Geziena M. Th. Schreuder,J. A. P. M. Ewals,J. P. Terwiel,H. K. Ronday,P. J. S. M. Kerstens,René E. M. Toes,René R. P. de Vries,F. C. Breedveld,B. A. C. Dijkmans,T. Huizinga,Cornelia F Allaart	2008	86
13	A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma Clinical Rheumatology ·Francis Swaneveld,Richard M. van Vugt,Jan Paul de Boer,B. A. C. Dijkmans,Willem F. Lems	2007	1
14	The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor Î± expression in the synovium Annals of the Rheumatic Diseases ·C A Wijbrandts,M.G.W. Dijkgraaf,Maarten C. Kraan,Marjolein Vinkenoog,Tom Smeets,Huibert J. Dinant,Koen Vos,Willem F. Lems,Gertjan Wolbink,D Sijpkens,B. A. C. Dijkmans,Paul P. Tak	2007	113
15	Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis Annals of the Rheumatic Diseases ·Melek Güler-Yüksel,J. Bijsterbosch,Y P M Goekoop-Ruiterman,FC Breedveld,Cornelia F Allaart,Jeska K de Vries‐Bouwstra,B. A. C. Dijkmans,W.F. Lems,H. K. Ronday,A. J. Peeters,J. M. De Jonge-Bok	2007	54
16	Remission and radiographic progression in rheumatoid arthritis. PubMed ·Alexandre E. Voskuyl,B. A. C. Dijkmans	2007	11
17	Differential expression of multidrug resistance-related proteins on monocyte-derived macrophages from rheumatoid arthritis patients Arthritis Research ·Ruud Oerlemans,B. A. C. Dijkmans,JW van der Heijden,W.F. Lems,Anneke W. Reurs,GL Scheffer,RJ Scheper,Gerrit Jansen	2005	3
18	No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis Arthritis & Rheumatism ·B. E. E. M. van den Borne,R. B. M. Landewé,I. Houkes,F. Schild,P. C. W. van der Heyden,J. M. W. Hazes,Jan P. Vandenbroucke,A. H. Zwinderman,H. S. Goei Thè,F. C. Breedveld,Hein J. Bernelot Moens,P. M. Kluin,B. A. C. Dijkmans	1998	3
19	Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. PubMed ·I. Speyer,F C Breedveld,B. A. C. Dijkmans	1998	36
20	THE FREQUENCY OF EXTREMELY LOW SERUM PEPSINOGEN, INDICATIVE OF CORPUS GASTRITIS WITH SEVERE ATROPHY, IN RHEUMATOID ARTHRITIS, OTHER CHRONIC RHEUMATIC DISEASES AND NON-RHEUMATIC DISEASES Lara D. Veeken ·M. Janssen,B. A. C. Dijkmans,Jan P. Vandenbroucke,I. Biemond,C. B. H. W. Lamers	1993	3

About B. A. C. Dijkmans

B. A. C. Dijkmans is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Hematology, having authored 24 papers that have together received 1.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (15 papers), Systemic Lupus Erythematosus Research (7 papers), Spondyloarthritis Studies and Treatments (5 papers), Bone and Joint Diseases (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Autoimmune and Inflammatory Disorders Research (3 papers) and Urticaria and Related Conditions (2 papers). The work is most often cited by research in Rheumatology (1.5k citations), Hematology (312 citations) and Immunology (394 citations). B. A. C. Dijkmans has collaborated with scholars based in Netherlands, United Kingdom and Norway. Frequent co-authors include Michael T. Nurmohamed, Tore K Kvien, Iain B. McInnes, Naveed Sattar, Zoltán Szekanecz, Prodromos Sidiropoulos, David McCarey, M.J. Peters, Miguel Á. González‐Gay and Deborah Symmons. Their work appears in journals such as Annals of the Rheumatic Diseases, Osteoporosis International and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact